TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
6,566
|
2,822
|
473 |
| Financial expenses |
1,178
|
1,403
|
1,897 |
| Earnings before taxes |
-13,717
|
-21,091
|
-22,746 |
| EBITDA |
-10,733
|
-17,557
|
-17,964 |
| Total assets |
13,380
|
14,869
|
21,701 |
| Current assets |
7,770
|
7,198
|
11,818 |
| Current liabilities |
7,400
|
3,838
|
7,709 |
| Equity capital |
5,980
|
11,031
|
13,992 |
| - share capital |
11,672
|
8,969
|
6,007 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
44.7%
|
74.2%
|
64.5% |
| Turnover per employee |
1,094
|
470
|
79 |
| Profit as a percentage of turnover |
-208.9%
|
-747.4%
|
-4808.9% |
| Return on assets (ROA) |
-93.7%
|
-132.4%
|
-96.1% |
| Current ratio |
105.0%
|
187.5%
|
153.3% |
| Return on equity (ROE) |
-229.4%
|
-191.2%
|
-162.6% |
| Change turnover |
3,744
|
2,349
|
424 |
| Change turnover % |
133%
|
497%
|
865% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.